Τόμος 14 (2000) – Τεύχος 1 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 14 (2000) – Issue 1 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Department of Medicine, King’s College School of Medicine and Dentistry, Bessemer Road, London SE5 89PJ, UK

Accepted for publication: 10 December 1999

pharmakonpress[at]pharmakonpress[.]gr

2.    Hawkes C.H.; Twin studies in medicine-what do they tell us? Quartely J. Med. 90: 311-321 (1997)

3.    Brix T.H., Christensen K., Holm N.V., Harvald B., Hegedus L.: A population based study of Graves’ disease in Danish twins, Clin. Endocrinol. (1998)

4.    Ratanachaiyavong S., Lloyd L., Darke C., McGregor A.M.: MHC-extended haplotypes in families of patients with Graves’ disease. Hum. Immunol. 36: 99-111 (1993)

5.    Yanagawa T., Mangklabruks A., De Groot L.J.: Strong association between HLA-DQA1*0501 and Graves’ disease in a male Caucasian population. J. Clin. Endocrinol. Metab. 79: 227-229 (1994)

6.    Cuddihy R.M., Bahn R.S.: Lack of an independent association between the human leukocyte antigen allele DGAr0501 and Graves’ disease. J. Clin. Endocrinol. Metab. 81: 847-849 (1996)

7.    Barlow A.B.T., Wheatcroft N., Watson P., Weetman A.P.: Association of HLA-DQA1*0501 with Graves’ disease in English Caucasian men and women. Clin. Endocrinol. 44: 73-77(1996)

8.    Blakemore A.I.F., Watson P.F., Weetman A.P. et al.: Association of Graves’ disease with an allele of the lnter-leukin-1 receptor antagonist gene. J. Clin. Endocrinol. Metab. 80: 111-115 (1995)

9.    Davies T.F., Martin. A, Conception E.S., Graves P., Cohen l., Ben-Nun A.: Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N. Engl. J. Med. 325: 238-244 (1991)

10.  Davies T.F., Martin A., Conception E.S., Graves P., Lahat N., Cohen W.L., Ben-Nun A.: (1992). Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J. Clin. Invest. 89: 157-162 (1992)

11.  McIntosh R.S., Tandon N., Pickerill A.P., Davies R., Barnett D., Weetman A.P.: IL-2 receptor-positive intrathyroidal lymphocytes in Graves’ disease: Analysis of Va transcript microheterogeneity. J. Immunol. 91: 3884-3893 (1993)

12.  Caso-Pelaez E., McGregor A.M., Banga J.P.: A polyclonal T cell receptoire of V-alpha and V-beta T cell receptor gene families in intrathyroidal T lymphocytes of Graves’ disease patients, Scand. J. Immunol. 41: 141-147 (1995)

13.  Reiser H., Stadecker M.J.: Co-stimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 335: 1369-1377 (1996)

14.  Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., De Groot L.J.: CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J. Clin. Endocrinol. Metab. 89: 41-45 (1995)

15.  Donner H., Rau H., Walfish P.G., Braun J., Siegmund T., Finke R., Herwig J., Usadel K.H., Badenhoop K.: CTLA-4 alanine-17 confers genetic susceptibility to Graves’ disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82: 143-146 (1997)

16.  Kotsa K., Watson P.F., Weetman A.P.: A CTLA-4 poly-morphism is associated with both Graves’ disease and autoimmune hypothyroidism. Clin. Endocrinol. 46: 551-554 (1997)

17.  Roman S.H., Greenberg D., Rubinstein P., Wallenstein S., Davies T.F.: Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J. Clin. Endocrinol. Metab. 74: 496-503 (1992)

18.  Shields D.C., Ratanachaiyavong S., McGregor A.M., Collins A., Morton N.E.: Combined segregation and linkage analysis of Graves’ disease with a thyroid autoantibody diathesis. Am. J. Hum. Genet. 55: 540-554 (1994)

19.  De Roux N.t Shields D.C., Misrahi M., Ratanachaiyavong S., McGregor A.M., Milgrom E.: Analysis of the thyrotropin receptor as a candidate gene in familial Graves’ disease. J. Clin. Endocrinol. Metab. 81: 3483-3486 (1996)

20.  Tomer Y., Barbesino G., Keddache M., Greenberg D.A., Davies T.F.: Mapping a major susceptibility locus for Graves’ disease (GD-1) to chromosome 14q31. J. Clin. Endocrinol. Metab. 82: 1645-1648 (1997)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr